Norges Bank’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-92,900
| Closed | -$2.5M | – | 2097 |
|
|
2022
Q2 | $2.5M | Buy |
+92,900
| New | +$2.5M | ﹤0.01% | 1873 |
|
|
2021
Q3 | – | Sell |
-32,200
| Closed | -$1.08M | – | 2283 |
|
|
2021
Q2 | $1.08M | Buy |
+32,200
| New | +$1.08M | ﹤0.01% | 2107 |
|
|
2017
Q2 | – | Sell |
-23,507
| Closed | -$1.27M | – | 2134 |
|
|
2017
Q1 | $1.27M | Hold |
23,507
| – | – | ﹤0.01% | 2030 |
|
|
2016
Q4 | $1.25M | Hold |
23,507
| – | – | ﹤0.01% | 2012 |
|
|
2016
Q3 | $1.36M | Sell |
23,507
-5,000
| -18% | -$289K | ﹤0.01% | 2012 |
|
|
2016
Q2 | $1.88M | Hold |
28,507
| – | – | ﹤0.01% | 2006 |
|
|
2016
Q1 | $1.62M | Sell |
28,507
-11,367
| -29% | -$644K | ﹤0.01% | 2013 |
|
|
2015
Q4 | $9.38M | Sell |
39,874
-4,601
| -10% | -$1.08M | ﹤0.01% | 1627 |
|
|
2015
Q3 | $7.03M | Hold |
44,475
| – | – | ﹤0.01% | 1749 |
|
|
2015
Q2 | $16.8M | Buy |
44,475
+13,037
| +41% | +$4.93M | 0.01% | 1291 |
|
|
2015
Q1 | $13.1M | Hold |
31,438
| – | – | 0.01% | 1485 |
|
|
2014
Q4 | $8.61M | Sell |
31,438
-3,665
| -10% | -$1M | ﹤0.01% | 1711 |
|
|
2014
Q3 | $6.82M | Sell |
35,103
-52,731
| -60% | -$10.3M | ﹤0.01% | 1789 |
|
|
2014
Q2 | $21.5M | Buy |
+87,834
| New | +$21.5M | 0.01% | 1587 |
|